Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson.
Looking at options history for Johnson & Johnson JNJ we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $243,931 and 8, calls, for a total amount of $399,729.
What's The Price Target?
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $160.0 for Johnson & Johnson during the past quarter.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale activity within a strike price range from $100.0 to $160.0 in the last 30 days.
Johnson & Johnson Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| JNJ | PUT | TRADE | BEARISH | 01/19/24 | $155.00 | $139.4K | 7.2K | 1 |
| JNJ | CALL | SWEEP | BEARISH | 01/17/25 | $105.00 | $125.8K | 9 | 26 |
| JNJ | CALL | TRADE | BULLISH | 01/16/26 | $100.00 | $69.2K | 11 | 0 |
| JNJ | CALL | SWEEP | BEARISH | 01/19/24 | $160.00 | $46.5K | 5.1K | 1.1K |
| JNJ | CALL | TRADE | BEARISH | 01/17/25 | $160.00 | $45.5K | 582 | 0 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Following our analysis of the options activities associated with Johnson & Johnson, we pivot to a closer look at the company's own performance.
Present Market Standing of Johnson & Johnson
- With a trading volume of 2,847,114, the price of JNJ is up by 0.77%, reaching $149.74.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 64 days from now.
What Analysts Are Saying About Johnson & Johnson
In the last month, 2 experts released ratings on this stock with an average target price of $215.0.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $215.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
